Key Highlights

  • Pin Tai and Nan Sun stepped down as directors effective in June.
  • Chung Fu Wing joins the board bringing extensive experience in multi‑asset investment across Asian markets.
  • Shangwei Chen adds a background in corporate restructuring and medical device distribution.

Chi Special Acquisition Corp. Disclosed a board reshuffle, marking the departure of two long‑standing directors and the addition of two seasoned executives. The changes, effective in June, are aimed at bolstering the SPAC’s strategic direction as it explores post‑listing opportunities.

Resignations Effective June

The filing noted that Pin Tai and Nan Sun resigned from the board for personal reasons. Their exit creates two open seats, prompting an immediate search for candidates with complementary expertise.

Veteran Investor Chung Fu Wing Joins Board

Chung Fu Wing was named to fill one vacancy. He brings a deep background in multi‑asset investment and advisory work across Asian markets. His résumé includes fund management recognition, multiple industry honors, and prior roles at Boston Consulting Group, Kearny, and Arthur Andersen.

Healthcare Specialist Shangwei Chen Added

Shangwei Chen was appointed to the second open seat. He possesses a strong background in corporate restructuring and healthcare management, having founded SJ Investment and led strategic fundraising and capital restructuring initiatives. He currently serves as Director and Executive Partner at a long‑standing medical device distributor.

Strategic Fit for Chi Special Acquisition Corp.

The new directors complement the SPAC’s focus on capital‑intensive sectors. Wing’s knowledge of Asian and global markets aligns with the firm’s ambition to source cross‑border deals, while Chen’s healthcare background supports potential ventures in medical technology and related fields.

Governance and Compensation Overview

Both appointees will receive compensation consistent with Chi Special Acquisition Corp.’s existing board framework. Their inclusion reinforces the company’s commitment to robust governance and aligns leadership incentives with shareholder interests.

Market Reaction Anticipated

While the announcement does not contain quantitative metrics, analysts typically monitor board composition changes for signals of strategic intent. The addition of high‑profile professionals may enhance investor confidence and could influence the SPAC’s valuation trajectory in upcoming trading sessions.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.